Research Group Aetiology and Inequalities in Childhood Cancer, Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Department of Prevention and Evaluation, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Pediatr Blood Cancer. 2024 Jun;71(6):e30954. doi: 10.1002/pbc.30954. Epub 2024 Mar 26.
Tumors of the central nervous system (CNS) are the second most common type of pediatric cancer in Germany. We aimed to describe registration practice, incidence, and survival patterns for childhood CNS tumors in Germany for the past 40 years.
Including all CNS tumor cases in children diagnosed at ages 0-14 years registered at the German Childhood Cancer Registry (GCCR) in 1980-2019 (for survival analysis 1980-2016), we calculated age-specific and age-standardized incidence rates (ASIR) over time, average annual percentage changes (AAPC), and 1- and 5-year overall survival.
While we observed a pronounced increase in ASIR after the establishment of the GCCR during the 1980s, ASIR for all pediatric CNS tumors combined continued to increase markedly from 28.6 per million in 1990-1999 to 43.3 in 2010-2019 (AAPC = 2.7% in 1991-2010, AAPC = 0.3% in 2010-2019). The 5-year overall survival from CNS tumors improved from 63% in the 1980s, 70% in the 1990s to 79% in 2010-2016. These improvements have occurred across all age groups. Children diagnosed with ependymomas and choroid plexus tumors experienced the strongest increase (from 54% to 81%).
Observed increases in incidence rates for pediatric CNS tumors are likely only partially caused by actual increasing case numbers. The majority is a function of improved registration and, to a minor extent, improvements in diagnostics. Survival from pediatric CNS tumors has, by and large, improved consistently, leading to a growing population of childhood cancer survivors with diverse health biographies and risk of lifelong adverse impact on health and wellbeing.
中枢神经系统(CNS)肿瘤是德国第二大常见的儿童癌症类型。我们旨在描述过去 40 年来德国儿童中枢神经系统肿瘤的登记实践、发病率和生存模式。
我们将德国儿童癌症登记处(GCCR)在 1980 年至 2019 年期间诊断为 0-14 岁的所有 CNS 肿瘤病例(用于生存分析为 1980 年至 2016 年)纳入研究,计算了随时间推移的年龄特异性和年龄标准化发病率(ASIR)、平均年百分比变化(AAPC)以及 1 年和 5 年总生存率。
虽然我们观察到在 20 世纪 80 年代 GCCR 建立后,ASIR 明显增加,但所有儿童中枢神经系统肿瘤的 ASIR 继续显著增加,从 1990-1999 年的 28.6/100 万增加到 2010-2019 年的 43.3/100 万(1991-2010 年的 AAPC 为 2.7%,2010-2019 年的 AAPC 为 0.3%)。CNS 肿瘤的 5 年总生存率从 20 世纪 80 年代的 63%、90 年代的 70%提高到 2010-2016 年的 79%。这些改善发生在所有年龄组。诊断为室管膜瘤和脉络丛肿瘤的儿童经历了最强的增长(从 54%增加到 81%)。
儿童中枢神经系统肿瘤发病率的增加可能仅部分归因于实际病例数量的增加。大部分是由于登记的改善,在较小程度上是由于诊断的改善。儿童中枢神经系统肿瘤的生存率总体上持续提高,导致越来越多的儿童癌症幸存者,他们有着不同的健康史,并面临着终生对健康和福利产生不利影响的风险。